Maplewood, NJ, United States of America

Dinos P Santafianos


Average Co-Inventor Count = 3.9

ph-index = 3

Forward Citations = 18(Granted Patents)


Location History:

  • Lawrenceville, NJ (US) (1993)
  • Maplewood, NJ (US) (1994 - 1998)

Company Filing History:


Years Active: 1993-1998

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Dinos P Santafianos: Innovator in Pharmaceutical Compounds

Introduction

Dinos P Santafianos is a notable inventor based in Maplewood, NJ (US). He has made significant contributions to the field of pharmaceuticals, holding a total of 4 patents. His work primarily focuses on compounds that have potential therapeutic applications.

Latest Patents

Among his latest patents is the development of 4-arylamino-benzopyran and related compounds. These compounds possess the formula ##STR1## and include pharmaceutically acceptable salts. They exhibit potassium channel activating activity, making them useful as cardiovascular agents. Another significant patent involves aryl and heterocyclic substituted propenamide derivatives. These novel compounds are particularly useful for treating ischemic conditions and arrhythmia, characterized by the formula ##STR1## where X can be oxygen or sulfur.

Career Highlights

Dinos has worked with prominent companies in the pharmaceutical industry, including E.R. Squibb & Sons, Inc. and Bristol-Myers Squibb Company. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Throughout his career, Dinos has collaborated with notable professionals such as Karnail S Atwal and Eric M Gordon. These collaborations have likely enhanced his research and development efforts in the pharmaceutical sector.

Conclusion

Dinos P Santafianos is a distinguished inventor whose work in pharmaceutical compounds has the potential to impact cardiovascular health and treat various medical conditions. His contributions through patents and collaborations highlight his importance in the field of innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…